Zydus receives USFDA's final approval for Indomethacin Suppository with competitive generic therapy designation
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Prednisolone Acetate Ophthalmic Suspension is the first generic version of Pred Forte
The product is expected to be launched in Q3FY25
This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa in India
Being the first approved applicant, Lupin is eligible for 180 days of CGT exclusivity
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
Nelarabine is in a class of medications called antimetabolites
Subscribe To Our Newsletter & Stay Updated